LGVN יחס מהיר Longeveron Corp

Longeveron Inc. (LGVN) is developing a biotechnological environment for the therapy of age-related pathologies via the Lomecel-B platform. The visualization of market value on GURU.Markets shows a value of 2.58. The business focuses on combating dementia and congenital heart defects in infants using a cellular approach. Furthermore, operational processes are protected by US law, minimizing any geopolitical threats or sanction risks.

To filter out default risks, it is essential for an investor to assess the issuer's ability to meet short-term obligations without liquidating inventories. This quick ratio is calculated as the ratio of cash and accounts receivable to current liabilities, which is critical for Longeveron Inc. (LGVN), as the R&D costs for Lomecel-B require a constant supply of liquid cash to maintain the pace of regenerative medicine.